-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
It is reported that starting from October 10th, citizens of Wuhan ushered in 113 types of medicines at reduced prices, including 61 nationally selected varieties, 19 alliance-purchased varieties, and 33 medicines that were successfully renewed by Wuhan municipal centralized procurement
.
With the introduction of these hundred kinds of reduced-price medicines in public medical institutions in Wuhan, the medical burden on citizens will be further reduced
.
On June 23 this year, the fifth batch of national organizations’ centralized procurement of selected varieties produced the results of the proposed selection in Shanghai.
This national procurement set a record high, with a large scale and a large variety of products, covering high blood pressure, Drugs for common and chronic diseases such as coronary heart disease, diabetes, and gastrointestinal diseases, as well as drugs for major diseases such as lung cancer, breast cancer, and colorectal cancer
.
The fifth batch of national centralized procurement of medicines that landed in Wuhan this time involved 61 varieties.
The average price of selected medicines was reduced by 56%, and the highest price reduction was 98.
3%
.
Among the 61 varieties, the prices of many commonly used drugs have dropped significantly.
For example, the price of esomeprazole injection for the treatment of acute gastric ulcers has dropped from 65 yuan per tube to 4 yuan per tube; the new generation of diabetes medicine saxagliptin has reduced prices 62%, the monthly fee dropped from 225 yuan to less than 90 yuan
.
At the same time, the cost of medication for a number of major diseases has also fallen sharply
.
For example, Sanofi's oxaliplatin (injection) for the treatment of colon cancer, the cost of each injection has been reduced from 1700 yuan to 310 yuan.
It is understood that the drug is used once every two weeks and can be used for the common people every 6 months.
Save 50,000 yuan
.
In addition, the prices of cephalosporin antibacterial drugs also dropped by an average of 75%
.
It is understood that the four cephalosporin species selected this time are ceftazolin, cefuroxime, ceftriaxone and ceftazidime, all of which are widely used clinically antibiotics
.
The 19 alliances’ purchases dropped by an average of 55%.
In June of this year, 8 provinces and autonomous regions led by Chongqing Municipality formed a purchasing alliance to purchase common drugs with large clinical usage and high purchase amounts.
Among them, Hubei Province was selected.
There are 19 varieties of drugs with 47 specifications, covering multiple therapeutic areas such as antimicrobial, antitumor, analgesia, digestive system, cardiovascular system, etc.
Compared with the historical purchase price, the average drop is 55.
03%, and the highest drop is 99.
40.
%
.
Judging from the selected supply list, the drugs with reduced prices include phloroglucinol injection, adenosylmethionine succinate for injection, calcium gluconate injection, compound glycyrrhizin tablets, cefoperazone sodium and sulbactam sodium for injection, Lodipine sustained-release tablets and so on
.
Among them, calcium saccharate injections are common varieties.
In recent years, the sales of this product in China's public medical institutions have maintained a year-on-year growth of more than 60%, and sales in 2019 have exceeded 650 million yuan
.
The drug has entered the 2019 National Medical Insurance Catalog, but its price has been controversial due to the previous monopolistic market behavior of raw materials
.
The industry believes that it is a trend for calcium gluconate injection to return to "people-friendly prices"
.
33 municipal-level renewal drugs further reduce the burden of citizens’ drug costs.
In addition to national procurement and inter-provincial centralized drug procurement, there are also 33 low-cost drugs that have been successfully renewed at the municipal level in Wuhan
.
It is reported that among the 33 renewed drugs, 6 of them passed the re-negotiation, and the price was reduced by 4% to 37% on the basis of the original selection; 11 varieties were successfully renewed through the bidding, and the price of the original selected product was reduced by an average of 34.
59.
%, the highest decrease is 82.
02%.
The above 17 varieties are re-negotiation or bidding, and the price is reduced on the basis of the original selected price.
Calculated based on the pre-purchasing volume of the selected products in the next cycle, it is expected that the total cost of medicines will be saved for the people of Wuhan.
83,276,500 yuan
.
.
With the introduction of these hundred kinds of reduced-price medicines in public medical institutions in Wuhan, the medical burden on citizens will be further reduced
.
On June 23 this year, the fifth batch of national organizations’ centralized procurement of selected varieties produced the results of the proposed selection in Shanghai.
This national procurement set a record high, with a large scale and a large variety of products, covering high blood pressure, Drugs for common and chronic diseases such as coronary heart disease, diabetes, and gastrointestinal diseases, as well as drugs for major diseases such as lung cancer, breast cancer, and colorectal cancer
.
The fifth batch of national centralized procurement of medicines that landed in Wuhan this time involved 61 varieties.
The average price of selected medicines was reduced by 56%, and the highest price reduction was 98.
3%
.
Among the 61 varieties, the prices of many commonly used drugs have dropped significantly.
For example, the price of esomeprazole injection for the treatment of acute gastric ulcers has dropped from 65 yuan per tube to 4 yuan per tube; the new generation of diabetes medicine saxagliptin has reduced prices 62%, the monthly fee dropped from 225 yuan to less than 90 yuan
.
At the same time, the cost of medication for a number of major diseases has also fallen sharply
.
For example, Sanofi's oxaliplatin (injection) for the treatment of colon cancer, the cost of each injection has been reduced from 1700 yuan to 310 yuan.
It is understood that the drug is used once every two weeks and can be used for the common people every 6 months.
Save 50,000 yuan
.
In addition, the prices of cephalosporin antibacterial drugs also dropped by an average of 75%
.
It is understood that the four cephalosporin species selected this time are ceftazolin, cefuroxime, ceftriaxone and ceftazidime, all of which are widely used clinically antibiotics
.
The 19 alliances’ purchases dropped by an average of 55%.
In June of this year, 8 provinces and autonomous regions led by Chongqing Municipality formed a purchasing alliance to purchase common drugs with large clinical usage and high purchase amounts.
Among them, Hubei Province was selected.
There are 19 varieties of drugs with 47 specifications, covering multiple therapeutic areas such as antimicrobial, antitumor, analgesia, digestive system, cardiovascular system, etc.
Compared with the historical purchase price, the average drop is 55.
03%, and the highest drop is 99.
40.
%
.
Judging from the selected supply list, the drugs with reduced prices include phloroglucinol injection, adenosylmethionine succinate for injection, calcium gluconate injection, compound glycyrrhizin tablets, cefoperazone sodium and sulbactam sodium for injection, Lodipine sustained-release tablets and so on
.
Among them, calcium saccharate injections are common varieties.
In recent years, the sales of this product in China's public medical institutions have maintained a year-on-year growth of more than 60%, and sales in 2019 have exceeded 650 million yuan
.
The drug has entered the 2019 National Medical Insurance Catalog, but its price has been controversial due to the previous monopolistic market behavior of raw materials
.
The industry believes that it is a trend for calcium gluconate injection to return to "people-friendly prices"
.
33 municipal-level renewal drugs further reduce the burden of citizens’ drug costs.
In addition to national procurement and inter-provincial centralized drug procurement, there are also 33 low-cost drugs that have been successfully renewed at the municipal level in Wuhan
.
It is reported that among the 33 renewed drugs, 6 of them passed the re-negotiation, and the price was reduced by 4% to 37% on the basis of the original selection; 11 varieties were successfully renewed through the bidding, and the price of the original selected product was reduced by an average of 34.
59.
%, the highest decrease is 82.
02%.
The above 17 varieties are re-negotiation or bidding, and the price is reduced on the basis of the original selected price.
Calculated based on the pre-purchasing volume of the selected products in the next cycle, it is expected that the total cost of medicines will be saved for the people of Wuhan.
83,276,500 yuan
.
